SIM
ONC

Sonora Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Sonora Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$3K Buy
+8
New +$2.62K ﹤0.01% 962

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Sonora Investment Management's ONC Position: Q3 2021 in Review

Sonora Investment Management opened a new position in BeOne Medicines Ltd (ONC) in Q3 2021: 8 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #962 among its holdings.

253 funds tracked by Wall St. Rank hold ONC as of Q3 2021.

  • Sonora Investment Management held 8 shares of BeOne Medicines Ltd worth $3K as of Q3 2021.
  • BeOne Medicines Ltd was a new Sonora Investment Management position in Q3 2021.
  • BeOne Medicines Ltd made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #962 holding.
  • 253 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.